Where does Mynosys Cellular Devices, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Mynosys Cellular Devices, Inc. ranks #26,920 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Mynosys Cellular Devices, Inc. hold?

Mynosys Cellular Devices, Inc. holds 10 US utility patents granted between 2015 and 2019, spanning 2 technology areas.

What is Mynosys Cellular Devices, Inc.'s Innovation Score?

Mynosys Cellular Devices, Inc. has an Innovation Score of 27.5 out of 100 (24th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Mynosys Cellular Devices, Inc. focus on?

Mynosys Cellular Devices, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 10 patents. Grants appear in 2 CPC subclasses total.

Is Mynosys Cellular Devices, Inc.'s patent grant rate increasing or decreasing?

Mynosys Cellular Devices, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Mynosys Cellular Devices, Inc.'s patents?

Mynosys Cellular Devices, Inc.'s patents average 23.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Mynosys Cellular Devices, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Mynosys Cellular Devices, Inc.

USPTO PatentsView assignee record - 10 granted patents across 2 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Mynosys ranks #26,920 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 2 technology areas.

#26,920
of 49,997 US assignees by volume: 24th percentile
by Innovation Score (27.5/100): 23.7
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26920 · US Corporation #26,920 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,920/49,997
PHOTO-FINISH Mühlbauer & KG
CPC-NARROW A61B · 2 areas
INNOV-THIN 27.5/100
CLAIMS-DENSE 23.7 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mühlbauer GmbH & Co. KG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Mynosys Cellular… · this assignee

28
3D Lighting… · lowest

7

What this shows Mynosys's Innovation Score is 27.5/100 (24th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Mynosys's grants concentrate

Mynosys Cellular Devices, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2015. By volume, Mynosys sits between MultiSensor Scientific, Inc. and Nanjing Institute OF Environmental Sciences, Ministry OF Ecology AND Environment.

Multisensor Scien…

10
Murtech

10
Mydor

10
Myndshft

10
Myntra Designs Pr…

10
Mühlbauer & KG

10
N3N

10
Nanjing Institute…

10
Mynosys Cellular… ◀

10

What this shows Mynosys holds 10 patents at rank #26,912, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Mynosys

By rank, the assignees closest to #26,912 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Mynosys's primary technology class.

Mynosys's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 24th percentile higher than 24% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Mynosys Cellular Devices, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	10.0%
2016	3	30.0%
2018	2	20.0%
2019	4	40.0%

Which technologies does Mynosys Cellular Devices, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 10

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 10

Top 2 of 2 technology areas

Where it ranks

Overall rank by patents

#26,920

of 49,997 tracked assignees

Innovation Score

27.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Mynosys Cellular Devices, Inc.'s patent record in context - here's where to go next.

Mynosys Cellular Devices, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #26,920 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Mynosys Cellular Devices, Inc. against MultiSensor Scientific, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.